Feedback / Questions
PMB-CT01 - PeproMene Bio
https://www.manilatimes.net/2025/05/20/tmt-newswire/pr-newswire/pepromene-bio-inc-and-the-institute-for-follicular-lymphoma-innovation-ifli-announce-the-first-follicular-lymphoma-fl-patient-treated-with-baff-r-targeting-car-t-cells-pmb-ct01-achieves-a-complete-response/2117688
May 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next